Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
The possible effects of the solar and geomagnetic activity on multiple sclerosis.
Mitochondrial DNA Variation and Heteroplasmy in Monozygotic Twins Clinically Discordant for Multiple Sclerosis.
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Rebif approval application
Management of multiple sclerosis and the integration of related specialty pharmacy programs within health systems.
European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging--measured disease activity and burden in patients with relapsing multiple sclerosis.
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial.
12-oxo-phytodienoic acid, a plant-derived oxylipin, attenuates lipopolysaccharide-induced inflammation in microglia.
Differences in the burden of psychiatric comorbidity in MS vs the general population.
The role of stem cell therapy in multiple sclerosis: An overview of the current status of the clinical studies.
Rapid, sustained and reversible pharmacodynamics of DAC HYP in MS patients supports mechanism of action via modulation of the IL-2 pathway
Magnetic resonance imaging of myelin using ultrashort Echo time (UTE) pulse sequences: Phantom, specimen, volunteer and multiple sclerosis patient studies.
Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS.
The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
A Combination Trial of Copaxone plus Estriol in Relapsing Remitting Multiple Sclerosis
The role of global and regional gray matter volume decrease in multiple sclerosis.
Ncx3 gene ablation impairs oligodendrocyte precursor response and increases susceptibility to experimental autoimmune encephalomyelitis.
10 years of interferon beta-1b (Beta feron therapy.
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
Multiple Sclerosis: An Update.
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis.

Pages